EXCELSIOR BIOPHARMA INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 6496 for the last quarter is 209.17 M TWD, and it's 12.14% higher compared to the previous quarter. The net income of Q4 23 is 6.24 M TWD.